Scientific Session
Scleroderma, Scleroderma Mimics, and Mixed Connective Tissue Disease (MCTD)
Kristin B. Highland, MD
Director, Rheumatic Lung Disease Program
Cleveland Clinic
Shaker Heights, Ohio, United States
Disclosure(s): Atyr Pharmaceuticals: Consultant (Ongoing), Grant/Research Support (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Forsee Pharmaceuticals: Consultant (Terminated, January 2, 2025); Gossamer Bio: Consultant (Ongoing), Grant/Research Support (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mitusbishi: Consultant (Terminated, February 3, 2025); United Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)